Chart by @VexTrades - Upcoming Events PDUFA date February 17, 2012 for Korlym (CORLUX) for the treatment of the manifestations of Cushing’s Syndrome. Click on chart to enlarge, then click on “expand” icon at top right for a clearer image.
Chart by @VexTrades - EDIT 12/15/11 – This chart is of little significance since following the posting BPAX released data showing it had failed its Phase 3 efficacy trials. Upcoming Events Phase 3 efficacy data of Libigel for Female sexual dysfunction due 4Q 2011. Stock does tend to sell off following the release of data so trade wisely! [...]
By @VexTrades - Upcoming Events December 2011 - Top-line results due from its retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy or FORTRESS, in the offspring of women who were exposed to topiramate during the first trimester of pregnancy. Data will be used as part of the QNEXA NDA resubmission [...]
By @VexTrades – Upcoming Events Phase 3 efficacy data of Libigel for Female sexual dysfunction due 4Q 2011. Safety data due 3Q 2012 and NDA filing due 4Q 2012. PDUFA 2/14/12 of Bio-T-Gel for male hypogonadism partnered with TEVA. Click on chart to enlarge, then click on “expand” icon at top right for a clearer [...]
Dear BioPharmCatalyst reader, I am pleased to announce that the chatroom has had a complete revamp for the benefit of all users of BioPharmCatalyst. The previous chatroom was admittedly poorly designed and as a result received little attention. It was not user-friendly and in fact most readers were unaware it existed. However, as of today [...]
Spectrum Pharmaceuticals (NasdaqGS: SPPI) announced the initiation of a Phase 2 trial of ZEVALIN for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin’s lymphoma (NHL). Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced efficacy and safety results from its Phase 2 trial of urocortin 2 in 53 patients [...]
Earlier today abstracts to next month’s ASCO meeting were released. Approximately 75 of those abstracts can now be found in the BioPharmCatalyst ASCO Calendar, which can be found HERE. Session times and other information can also be found to give you a one-stop resource provided to save you much time in searching for abstracts.
Recent Comments